13th ESPID Research Masterclass

13th ESPID Research Masterclass

The extended ERMC deadline is March 13

Thank you for your submissions! Abstract submissions are now closed.

General:

The  ESPID Research Masterclass (ERMC) is a closed, seminar type of forum for active paediatric infectious diseases (PID) research groups in Europe. The research performed can involve ‘bench-type’ basic and translational research, as well as ‘bed-side’ clinical studies (e.g. observational, case-control, randomized controlled, interventional) and epidemiological studies in any area of paediatric infectious diseases.

The organizing team strongly encourages research groups to attend the entire ESPID 2021 Annual Meeting to be held 24th – 29th May 2021.


Why should I apply for the ERMC?

The primary aim of ERMC is to provide better opportunities for young researchers to present their studies and discuss their research with other junior colleagues as well as with European research group leaders. During the Masterclass, the junior researchers will be trained on how to present their data, ask questions or chair a session. They will receive guidelines for scientific discussion in a seminar type of positive atmosphere. The second aim of the seminar is to provide the researchers with a better view of recent PID research in Europe and also to stimulate discussions of new research collaborations among ESPID members.

 

Who is eligible to participate in the ERMC?

The ERMC is based on the attendance of research teams. The research groups should apply their attendance as a group of one (1) senior and maximum three (3) junior researchers (maximum group size is four (4) persons). The senior researcher in the group should be an ESPID member.

 

Financial Support

  • Registration is being managed in conjunction with the travel award scheme.

 

How do I submit a group application?

  • Applications for ERMC are submitted via the online submission system.
  • Application Deadline (including abstract submission): February 28, 2021 Now March 13, 2021
  • Abstract Guidelines:
    • A short summary (max. one page, A4) of current research interests of the group
    • A list of 10 recent publications from the group
    • A brief CV (max 2 pages) from each junior member including current position, degrees, publications, presentations at (inter)national meetings, and number of years spent on research
    • Abstracts* from individual junior members
    • A list of the participants (1 senior, max. 3 juniors) with their e-mail addresses
    • A one slide PowerPoint presentation of the team

* The abstract should not exceed 280 words in total and must be structured into separate sections. The format of ERMC is well suited to present work-in-progress resulting in getting valuable feedback and input from other research groups on how to approach the research question, as well as discussing the study design with senior research leaders in paediatric infectious diseases and obtain their expert opinion.

The following format for the individual abstract should be used:

  • Title not exceeding 16 words
  • Authors and affiliations
  • Research question including the context and purpose of the study
  • Methods including rational why a particular method was chosen to answer the research question
  • Results can be ranging from work in progress to preliminary data, to more conclusive results
  • Conclusion including problems encountered, adjustment of methods and work plan for the next year.

Following the submission of the research team’s application, each proposed speaker will get an email with a link to directly submit their abstract. Each junior member will need to submit an abstract via the link by using their account details. The application is not final until the junior member’s abstracts are submitted. The deadline to submit the abstracts connected to your ERMC application is now March 13, 2021. Abstracts received after this date have not been accepted.

Please note that 1-2 of junior members from each team should be ready to give an oral presentation of their research.